The large volume wearable injectors market is projected to grow at an annualized rate of ~35% - till 2030

Roots Analysis has done a detailed study on Large Volume Wearable Injectors Market (5th Edition), 2020-2030: Focus on Bolus, Basal and Continuous Delivery Devices.”, covering key aspects of the industry’s current trends and identifying potential future growth opportunities.

 

To order this 540+ page report, which features 175+ figures and 200+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/large-volume-wearable-injectors/238.html

 

Key Market Insights

• More than 40 large volume wearable injectors are presently available / under development for the administration of drugs, beyond insulin, including 15+ drug device combinations
• Companies focused on developing devices for the delivery of insulin have already established strong brand positions in this domain, with 30+ devices currently under development or available
• More than 200 biologics / small molecule drugs were identified as likely products to be developed in combination with large volume wearable injectors
• The rising interest in this field is reflected in the number of partnerships (90+) inked between 2015

 and 2020 (till June), involving both international and indigenous stakeholders, across the world

• An evaluation of 50+ stakeholders engaged in the development of large volume wearable injectors revealed the existence of several likely acquisition targets, across different geographical regions
• The market, for the large volume wearable injectors for the delivery of non-insulin drugs  is projected to be worth USD 600 million; owing to the increasing incidence of chronic clinical conditions and growing pipeline of therapeutic interventions to treat such diseases
• The large volume wearable injectors market for insulin is anticipated to be worth over USD 2.7 billion by 2030; the anticipated opportunity is likely to be distributed across various different device types, therapeutic areas and geographies

 

For more information, please visit https://www.rootsanalysis.com/reports/view_document/large-volume-wearable-injectors-market-4th-edition-2018-2030/238.html

                                                                                                               

Table of Contents

 

1.         PREFACE

1.1.       Scope of the Report

1.2.       Research Methodology

1.3.       Chapter Outlines

 

2.         EXECUTIVE SUMMARY

 

3.         INTRODUCTION

3.1.       Chapter Overview

3.2.       An Overview of Drug Delivery Devices

3.3.       Conventional Parenteral Drug Delivery

3.3.1     Needlestick Injuries

 

3.4.       Emergence of Self-Administration Devices

3.4.1.    Driving Factors

 

3.5.       Available Self-Injection Devices

3.5.1.    Prefilled Syringes

3.5.2.    Pen-Injectors

3.5.3.    Needle-Free Injectors

3.5.4.    Autoinjectors

3.5.5.    Large Volume Wearable Injectors

 

3.6.       Regulatory Considerations

3.6.1.    Medical Devices

3.6.2.    Drug Device Combination Products

 

3.7.       Future Perspectives of Self-Injection Systems

 

4.         LARGE VOLUME WEARABLE INJECTORS: CURRENT MARKET LANDSCAPE

4.1.       Chapter Overview

4.2.       Large Volume Wearable Injectors: Overall Market Landscape

4.2.1.    Large Volume Wearable Injectors for Non-Insulin Drugs: Market Landscape

4.2.1.1. Analysis by Stage of Development

4.2.1.2. Analysis by Type of Device

4.2.1.3. Analysis by Type of Dose

4.2.1.4. Analysis by Route of Administration

4.2.1.5. Analysis by Mode of Injection

4.2.1.6. Analysis by Volume / Storage Capacity

4.2.1.7. Analysis by Actuation Mechanism

4.2.1.8. Analysis by Usability

4.2.1.9. Analysis by Availability of Prefilled Drug Reservoir

4.2.1.10. Analysis by Availability of Connectivity

 

4.2.2.    Large Volume Drug Device Combinations: Market Landscape

4.2.2.1. Analysis by Stage of Development

4.2.2.2. Analysis by Type of Device

4.2.2.3. Analysis by Drug Compatibility

4.2.2.4. Analysis by Type of Dose

4.2.2.5. Analysis by Route of Administration

4.2.2.6. Analysis by Mode of Injection

4.2.2.7. Analysis by Therapeutic Area

4.2.2.8. Analysis by Volume / Storage Capacity

4.2.2.9. Analysis by Usability

 

4.2.3. Large Volume Wearable Injectors for Non-Insulin Drugs: Analysis of Developers (Devices    and Drug Device Combinations)

4.2.3.1. Analysis by Year of Establishment

4.2.3.2. Analysis by Company Size

4.2.3.3. Analysis by Geography

 

4.2.4.    Large Volume Wearable Injectors for Insulin: Market Landscape

4.2.4.1. Analysis by Stage of Development

4.2.4.2. Analysis by Type of Device

4.2.4.3. Analysis by Volume / Storage Capacity

4.2.4.4. Analysis by Usability

4.2.4.5. Analysis by Availability of Prefilled Insulin Cartridges

4.2.4.6. Analysis by Availability of CGM / BGM System

4.2.4.7. Analysis by Availability of Automated Insulin Delivery (AID) Feature

4.2.4.8. Analysis by Availability of Connectivity

4.2.4.9. Analysis by Type of Remote Control Features

 

4.2.5.    Large Volume Wearable Injectors for Insulin: Analysis of Developers

4.2.5.1. Analysis by Year of Establishment

4.2.5.2. Analysis by Company Size

4.2.5.3. Analysis by Geography

 

5.         PRODUCT COMPETITIVENESS ANALYSIS

5.1.       Chapter Overview

5.2.       Methodology

5.3.       Assumptions / Key Parameters

5.4.       Product Competitiveness Analysis

5.4.1.    Large Volume Wearable Injectors for Non-Insulin Drugs

5.4.2.    Large Volume Drug Device Combinations

5.4.3.    Large Volume Wearable Injectors for Insulin

 

6.         LARGE VOLUME WEARABLE INJECTORS: KEY PLAYERS

6.1.       Chapter Overview

6.2.       Large Volume Wearable Injectors for Non-Insulin Drugs: Key Players

6.2.1.    Becton Dickinson

6.2.1.1. Company Snapshot

6.2.1.2. Financial Information

6.2.1.3. Product Portfolio

6.2.1.4. Recent Developments and Future Outlook

6.2.2.    Bespak

6.2.2.1. Company Snapshot

6.2.2.2. Financial Information

6.2.2.3. Product Portfolio

6.2.2.4. Recent Developments and Future Outlook

 

6.2.3.    Enable Injections

6.2.3.1. Company Snapshot

6.2.3.2. Product Portfolio

6.2.3.3. Recent Developments and Future Outlook

 

6.2.4.    Insulet

6.2.4.1. Company Snapshot

6.2.4.2. Financial Information

6.2.4.3. Product Portfolio

6.2.4.4. Recent Developments and Future Outlook

 

6.2.5.    Roche

6.2.5.1. Company Snapshot

6.2.5.2. Financial Information

6.2.5.3. Product Portfolio

6.2.5.4. Recent Developments and Future Outlook

 

6.2.6.    Sensile Medical

6.2.6.1. Company Snapshot

6.2.6.2. Product Portfolio

6.2.6.3. Recent Developments and Future Outlook

 

6.2.7.    Sonceboz

6.2.7.1. Company Snapshot

6.2.7.2. Product Portfolio

6.2.7.3. Recent Developments and Future Outlook

 

6.2.8.    SteadyMed Therapeutics

6.2.8.1. Company Snapshot

6.2.8.2. Product Portfolio

6.2.8.3. Recent Developments and Future Outlook

 

6.2.9.    Weibel CDS